INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 300 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,884 | -27.8% | 200 | 0.0% | 0.00% | – |
| Q2 2023 | $8,148 | +9.9% | 200 | 0.0% | 0.00% | – |
| Q1 2023 | $7,416 | +7.0% | 200 | 0.0% | 0.00% | – |
| Q4 2022 | $6,930 | -37.8% | 200 | 0.0% | 0.00% | – |
| Q3 2022 | $11,150 | -24.9% | 200 | -27.3% | 0.00% | – |
| Q2 2022 | $14,853 | -29.1% | 275 | 0.0% | 0.00% | – |
| Q1 2022 | $20,936 | -47.3% | 275 | -21.4% | 0.00% | – |
| Q4 2021 | $39,739 | – | 350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,615,321 | $23,697,000 | 41.29% |
| ARK Investment Management | 8,741,432 | $128,237,000 | 3.23% |
| Nikko Asset Management Americas, Inc. | 7,178,520 | $105,309,000 | 1.66% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $1,635,000 | 0.86% |
| Elmwood Wealth Management, Inc. | 64,204 | $942,000 | 0.82% |
| 361 CAPITAL LLC | 94,772 | $1,390,000 | 0.38% |
| Artal Group S.A. | 199,700 | $2,930,000 | 0.11% |
| StoneX Group Inc. | 14,982 | $220,000 | 0.09% |
| Sumitomo Mitsui Trust Holdings, Inc. | 7,178,520 | $105,309,000 | 0.08% |
| PDT Partners, LLC | 85,517 | $1,255,000 | 0.08% |